| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |